# US 2021/0330691 A1 · Methods of using cosmetic compositions comprising exopolysaccharides derived from microbial mats

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330691 A1
- Document ID: US20210330691A1
- Status: Published application
- Kind: A1
- Application number: 17/302,784
- Filed: 2021-05-12
- Published: 2021-10-28
- Earliest claimed: 2008-04-15
- Assignees: Lucas Meyer Cosmetics Canada Inc.
- Applicants: Lucas Meyer Cosmetics Canada Inc.
- Inventors: Estelle LOING; Sandrine BRIATTE; Patrice DIONNE; Martin BEAULIEU; Xavier MOPPERT; Laurent RICHERT; Catherine VAYSSIER
- Web page: https://patentgrep.com/patent/US20210330691A1

## CPC

- A61K 31/715: Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K 8/73: Polysaccharides
- A61K 8/99: from microorganisms other than algae or fungi, e.g. protozoa or bacteria
- A61P 17/00: Drugs for dermatological disorders
- A61Q 19/08: Anti-ageing preparations
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

A skin care composition is disclosed comprising at least one exopolysaccharide (EPS) originating from a microbial mat, the EPS being in a concentration of about 0.001% w/w to about 1.5% w/w of the composition. Uses and methods of use thereof. In specific embodiments, the EPSs are derived from microorganisms isolated from microbial mats found in French Polynesia. The composition is useful in reducing signs of skin aging and environmental damage by altering skin cell metabolism and improving hydration.

## Claims

### Claim 1

A method of reducing at least one skin aging sign in a subject comprising administering on the skin of the subject an effective amount of a composition comprising at least one isolated native exopolysaccharide (EPS), wherein the at least one EPS comprises Pol-6 or Pol-5, the EPS being in a concentration of about 0.001% w/w to about 1.5% w/w of the composition, wherein:
a) said Pol-6:
i) has a molar ratio of about 0.7 rhamnose and 0.7 mannose for a glucose reference of 10.0, as determined by gas chromatography;
ii) does not comprise galactose, xylose, and galacturonic acid, as determined by gas chromatography; and
iii) is secreted by a Vibrio alginolyticus bacterial strain originally isolated from a kopara microbial mat; and
b) said Pol-5:
i) has a molar ratio of about 3.2 D-glucose, 2.9 D-galactose, 0.5 D-mannose, 2.0 D-glucuronic acid and 1.0 D-galacturonic acid, as determined by gas chromatography; and
iii) is secreted by an Alteromonas macleodii bacterial strain originally isolated from a kopara microbial mat.

### Claim 2 (depends on 1)

The method of claim 1, wherein the at least one EPS comprises Pol-6 and Pol-5.

### Claim 3 (depends on 1)

The method of claim 1, wherein the method improves hydration of the skin.

### Claim 4 (depends on 1)

The method of claim 1, wherein the method improves the morphology of stratum corneum.

### Claim 5 (depends on 1)

The method of claim 1, wherein the method improves skin microrelief.

### Claim 6 (depends on 1)

The method of claim 1, wherein the method improves skin desquamation.

### Claim 7 (depends on 1)

The method of claim 1, wherein the method improves keratinocytes differentiation.

### Claim 8 (depends on 2)

The method of claim 2, wherein the method decreases bacterial adhesion on skin surface.

### Claim 9 (depends on 1)

The method of claim 1, wherein the method stimulates epidermis total lipid synthesis.

### Claim 10 (depends on 1)

The method of claim 1, wherein the method stimulates the expression of at least one gene involved in skin desquamation.

### Claim 11 (depends on 10)

The method of claim 10, wherein the gene is kallikrein 5, neurosin or stratum corneum chymotryptic enzyme.

### Claim 12 (depends on 1)

The method of claim 1, wherein the method stimulates the expression of at least one gene involved in keratinocytes differentiation.

### Claim 13 (depends on 12)

The method of claim 12, wherein the gene is filaggrin, loricrin or involucrin.

### Claim 14 (depends on 1)

The method of claim 1, wherein the method stimulates the expression of transglutaminase.

### Claim 15

A method of reducing at least one skin aging sign in a subject, comprising administering an effective amount of at least one isolated native exopolysaccharide (EPS) on the skin of the subject, wherein the at least one EPS comprises Pol-6 or Pol-5, and wherein:
a) said Pol-6:
i) has a molar ratio of about 0.7 rhamnose and 0.7 mannose for a glucose reference of 10.0, as determined by gas chromatography;
ii) does not comprise galactose, xylose, and galacturonic acid, as determined by gas chromatography; and
iii) is secreted by a Vibrio alginolyticus bacterial strain originally isolated from a kopara microbial mat; and
b) said Pol-5:
i) has a molar ratio of about 3.2 D-glucose, 2.9 D-galactose; 0.5 D-mannose, 2.0 D-glucuronic acid and 1.0 D-galacturonic acid, as determined by gas chromatography; and
iii) is secreted by an Alteromonas macleodli bacterial strain originally isolated from a kopara microbial mat.

### Claim 16 (depends on 1)

The method of claim 1, wherein the at least one EPS comprises Pol-6 and Pol-5.

### Claim 17 (depends on 2)

The method of claim 2, wherein each EPS originates from a different kopara microbial mat.

### Claim 18 (depends on 16)

The method of claim 16, wherein each EPS originates from a different kopara microbial mat.
